tlooto

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.

O. Forlenza, B. Diniz, A. Teixeira, F. Stella, W. Gattaz

2013.10.14Brazilian Journal of Psychiatry

Paper details

Journal
Brazilian Journal of Psychiatry
Published
2013.10.14
Citations
25
References
145
Access
Open Access
Fields
Biology, Medicine, Psychology

tlooto Summary

Different biomarkers are useful for the early diagnosis and prediction of AD in at-risk subjects, Nonetheless, important methodological limitations need to be overcome for widespread use of biomarkers in research and clinical settings.

Abstract

OBJECTIVE To present a critical review of publications reporting on the rationale and clinical implications of the use of biomarkers for the early diagnosis of Alzheimer's disease (AD).

METHODS We conducted a systematic search of the PubMed and Web of Science electronic databases, limited to articles published in English between 1999 and 2012, and based on the following terms: mild cognitive impairment, Alzheimer's disease OR dementia, biomarkers. We retrieved 1,130 articles, of which 175 were reviews. Overall, 955 original articles were eligible.

RESULTS The following points were considered relevant for the present review: a) rationale for biomarkers research in AD and mild cognitive impairment (MCI); b) usefulness of distinct biomarkers for the diagnosis and prediction of AD; c) the role of multimodality biomarkers for the diagnosis and prediction of AD; d) the role of biomarkers in clinical trials of patients with AD and MCI; and e) current limitations to the widespread use of biomarkers in research and clinical settings.

CONCLUSION Different biomarkers are useful for the early diagnosis and prediction of AD in at-risk subjects. Nonetheless, important methodological limitations need to be overcome for widespread use of biomarkers in research and clinical settings.

Citation format

FORLENZA, O., et al. Mild cognitive impairment. part 2: Biological markers for diagnosis and prediction of dementia in alzheimer's disease. Brazilian Journal of Psychiatry, 2013, 35 3(3): 284–94.